Search results
138 results found
Can genomic medicine attract, recruit and retain clinical bioinformaticians?BlogGenomic medicine demands a range of new workforce skills, and the good news is that the NHS is already making progress.
New and improved innovation unit to lead on accelerated accessBlogDr Philippa Brice comments on the Department for Health and Social Care announcement of the creation of a new national unit to oversee innovation and medicines
How does the GDPR apply to genomic data?BlogColin Mitchell sets out why our work to clarify the impact of the GDPR on the use of genomic data is so necessary. The work is funded by the Information Commissioner's Office
Dementia risk prediction modelsBlogWhile substantial progress has been made dementia remains a stubbornly difficult condition to prevent and treat
CAR-T: immunotherapy for blood cancerBlogIn the UK, steps are being taken to make delivery of regenerative medicines such as CAR-T a reality – Dr Emma Johnson provides an overview of the current state of play in this promising area for cancer therapies
The hope and hype surrounding polygenic risk scoresBlogDespite huge interest in PRS, this is still an emerging field with many technical hurdles to overcome
How to lead the world (in genomic healthcare)BlogThe government’s ongoing commitment to leverage investment in genomics for both healthcare and commercial benefits could not be clearer...however, there are many complexities that must be navigated to ensure a successful balance between health and wealth.
Ensuring the NHS Long Term Plan deliversBlogThe NHS Long Term Plan for England aims to allocate a reported new £570 billion funding package to build an NHS that is fit for the future. Can it deliver? Yes – if it sticks to the plan, says PHG Foundation Director, Dr Mark Kroese
Technology and humanity in healthcare: the Topol ReviewBlogThe eagerly awaited Topol Review for Health Education England has been released, PHG Foundation's Philippa Brice considers the recommendations.